COMPANY
Revive Rx LLC dba Revive Rx Pharmacy
Revive Rx LLC dba Revive Rx Pharmacy: recalling firm for Tirzepatide, as stated by public registers.
RECALLING FIRM
Recalled a product naming the peptide (FDA enforcement report).
| Tirzepatide | Class I recall, Ongoing, 2024-06-05 Regulator openFDA |
|---|---|
| Tirzepatide | Class II recall, Ongoing, 2023-05-31 Regulator openFDA |
What a register states, not an endorsement or an accusation by this site. All companies.
WEEKLY
Register Watch, weekly
New trials, approvals and enforcement actions. One email a week.